[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fEAWgM4OiLQSb0Mt8hzl4A9uCERgAxE_dK-WSYwbE2J4":3,"$fvHfrSD_dQrVp-sZAk3Q5LijQqOXqxc3adZMc948gIFQ":247},{"company":4,"items":17,"total":14},{"id":5,"slug":6,"company_name":7,"website_url":8,"country_code":9,"source_name":10,"source_url":11,"profile_summary":8,"legal_name":8,"legal_form":8,"registry_court":8,"registry_number":8,"vat_id":8,"impressum_address":8,"enrichment_sources_json":8,"enrichment_model":8,"enrichment_updated_at":8,"enrichment_error":8,"first_seen_at":12,"updated_at":13,"award_count":14,"total_value_eur":15,"latest_award_at":16},3509,"eurimpharm-arzneimittel-gmbh","EurimPharm Arzneimittel GmbH",null,"DEU","ted-v3","https://ted.europa.eu/de/notice/-/detail/367392-2026","2026-06-11 06:06:45","2026-07-11 23:57:11",29,4,"2026-07-08T00:00:00.000Z",[18,37,51,62,69,77,86,95,102,113,121,128,135,142,152,159,169,179,188,197,206,213,222,229,238],{"award_id":19,"tender_id":20,"source_name":10,"source_award_id":21,"source_url":22,"award_notice_type":23,"award_date":24,"publication_date":16,"lot_number":25,"contract_title":26,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":32,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":36,"tender_deadline_utc":8},480961,151181,"469114-2026","https://ted.europa.eu/de/notice/-/detail/469114-2026","can-standard","2025-08-01T00:00:00.000Z","LOT-0001","Nilotinib (ausgenommen als Dispersion in Apfelmus), ATC L01EA03","HRB 13886","EUR",0.97,"public","free","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Nilotinib (ausgenommen als DISP in Apfelmus) f. d. Z. 01.8.25 - 31.7.27 (zzgl. Verlängerungsoption 1x12 Mon.)","DAK-Gesundheit","DE","33600000","2026-07-07T22:00:00.000Z",{"award_id":38,"tender_id":39,"source_name":10,"source_award_id":40,"source_url":41,"award_notice_type":23,"award_date":8,"publication_date":42,"lot_number":43,"contract_title":44,"winner_name":7,"winner_identifier":45,"winner_country":9,"value_eur":46,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":47,"buyer_name":48,"region_code":49,"cpv_code":35,"tender_published_at_utc":50,"tender_deadline_utc":8},318276,150529,"462497-2026","https://ted.europa.eu/de/notice/-/detail/462497-2026","2026-07-06T00:00:00.000Z","LOT-0000","Abschluss eines nicht-exklusiven Rabattvertrages gemäߧ 130a Abs. 8 SGB V zwischen der IKK classic und der EurimPharm Arzneimittel GmbH zu Zutectra (R)","keine Angabe",1,"Deutschland – Arzneimittel – Abschluss eines nicht-exklusiven Rabattvertrages gemäߧ 130a Abs. 8 SGB V zwischen der IKK classic und der EurimPharm Arzneimittel GmbH zu Zutectra (R)","IKK classic","DE-SN","2026-07-05T22:00:00.000Z",{"award_id":52,"tender_id":53,"source_name":10,"source_award_id":54,"source_url":55,"award_notice_type":23,"award_date":56,"publication_date":57,"lot_number":25,"contract_title":58,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":59,"buyer_name":33,"region_code":60,"cpv_code":35,"tender_published_at_utc":61,"tender_deadline_utc":8},479773,149948,"459153-2026","https://ted.europa.eu/de/notice/-/detail/459153-2026","2024-07-01T00:00:00.000Z","2026-07-03T00:00:00.000Z","Etravirin, ATC J05AG04","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Etravirin, ATC J05AG04 für die Zeit 01.07.2024 - 30.06.2026","DE-HH","2026-07-02T22:00:00.000Z",{"award_id":63,"tender_id":64,"source_name":10,"source_award_id":65,"source_url":66,"award_notice_type":23,"award_date":56,"publication_date":57,"lot_number":25,"contract_title":67,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":68,"buyer_name":33,"region_code":60,"cpv_code":35,"tender_published_at_utc":61,"tender_deadline_utc":8},479824,153042,"460579-2026","https://ted.europa.eu/de/notice/-/detail/460579-2026","Dornase alfa, ATC R05CB13","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Dornase alfa, ATC R05CB13 für die Zeit 01.07.2024 - 30.06.2026",{"award_id":70,"tender_id":71,"source_name":10,"source_award_id":72,"source_url":73,"award_notice_type":23,"award_date":74,"publication_date":57,"lot_number":25,"contract_title":75,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":76,"buyer_name":33,"region_code":60,"cpv_code":35,"tender_published_at_utc":61,"tender_deadline_utc":8},479836,152948,"460626-2026","https://ted.europa.eu/de/notice/-/detail/460626-2026","2025-03-01T00:00:00.000Z","Erythropoietin ausschließlich Epoetin alfa, ATC B03XA01","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Erythropoietin ausschließlich Epoetin alfa, ATC B03XA01 für die Zeit 01.03.2025 - 28.02.2027",{"award_id":78,"tender_id":79,"source_name":10,"source_award_id":80,"source_url":81,"award_notice_type":23,"award_date":82,"publication_date":83,"lot_number":25,"contract_title":84,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":85,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":36,"tender_deadline_utc":8},474738,151178,"431583-2026","https://ted.europa.eu/de/notice/-/detail/431583-2026","2024-04-01T00:00:00.000Z","2026-06-24T00:00:00.000Z","Rivaroxaban, ATC B01AF01","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Amifampridin, ATC N07XX05 für die Zeit 01.09.2025 - 31.08.2027 (zzgl. Verlängerungsoption 1x12 Monate)",{"award_id":87,"tender_id":88,"source_name":10,"source_award_id":89,"source_url":90,"award_notice_type":23,"award_date":82,"publication_date":91,"lot_number":25,"contract_title":92,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":93,"buyer_name":33,"region_code":60,"cpv_code":35,"tender_published_at_utc":94,"tender_deadline_utc":8},427787,143623,"410574-2026","https://ted.europa.eu/de/notice/-/detail/410574-2026","2026-06-16T00:00:00.000Z","Interferon beta-1b, ATC L03AB08","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Interferon beta-1b, ATC L03AB08 für die Zeit 01.04.2024 - 31.03.2026","2026-06-15T22:00:00.000Z",{"award_id":96,"tender_id":97,"source_name":10,"source_award_id":98,"source_url":99,"award_notice_type":23,"award_date":74,"publication_date":91,"lot_number":25,"contract_title":100,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":101,"buyer_name":33,"region_code":60,"cpv_code":35,"tender_published_at_utc":94,"tender_deadline_utc":8},469263,144005,"413359-2026","https://ted.europa.eu/de/notice/-/detail/413359-2026","Pegfilgrastim, ATC L03AA13","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Pegfilgrastim, ATC L03AA13 für die Zeit 01.03.2025 - 28.02.2026 (zzgl. Verlängerungsoption 1x12 Monate)",{"award_id":103,"tender_id":104,"source_name":10,"source_award_id":105,"source_url":106,"award_notice_type":23,"award_date":8,"publication_date":107,"lot_number":108,"contract_title":109,"winner_name":7,"winner_identifier":8,"winner_country":8,"value_eur":8,"currency":8,"confidence":110,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":111,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":112,"tender_deadline_utc":8},5019,24892,"368527-2026","https://ted.europa.eu/de/notice/-/detail/368527-2026","2026-05-29T00:00:00.000Z","3","Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Eisen (parenterale Zubereitungen), ATC B03AC01 f. d. Z. 01.11.25-31.10.27 (zzgl.Verlängerungsoption 1x12 Mon)",0.92,"Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Hydrocortison (ausschl Dafo TAB), ATC H02AB09 f.d.Z. 01.10.25-30.09.27 (zzgl.Verlängerungsoption 1x12 Monate)","2026-05-28T22:00:00.000Z",{"award_id":114,"tender_id":115,"source_name":10,"source_award_id":116,"source_url":117,"award_notice_type":23,"award_date":118,"publication_date":107,"lot_number":25,"contract_title":119,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":120,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":112,"tender_deadline_utc":8},379974,24858,"367346-2026","https://ted.europa.eu/de/notice/-/detail/367346-2026","2026-01-01T00:00:00.000Z","Formoterol + Beclometason (ausschließlich Darreichungsform DOS), ATC R03AK08","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Formoterol + Beclometason (ausschließlich Dafo. DOS), ATC R03AK08 für die Zeit 01.01.2026 - 31.03.2026",{"award_id":122,"tender_id":123,"source_name":10,"source_award_id":124,"source_url":11,"award_notice_type":23,"award_date":125,"publication_date":107,"lot_number":25,"contract_title":126,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":127,"buyer_name":33,"region_code":60,"cpv_code":35,"tender_published_at_utc":112,"tender_deadline_utc":8},379981,24791,"367392-2026","2024-06-01T00:00:00.000Z","Bexaroten, ATC L01XF03","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Bexaroten, ATC L01XF03 für die Zeit 01.06.2024 - 31.05.2026",{"award_id":129,"tender_id":130,"source_name":10,"source_award_id":131,"source_url":132,"award_notice_type":23,"award_date":125,"publication_date":107,"lot_number":25,"contract_title":133,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":134,"buyer_name":33,"region_code":60,"cpv_code":35,"tender_published_at_utc":112,"tender_deadline_utc":8},380160,24939,"369372-2026","https://ted.europa.eu/de/notice/-/detail/369372-2026","Fondaparinux, ATC B01AX05","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Fondaparinux, ATC B01AX05 für die Zeit 01.06.2024 - 31.05.2026",{"award_id":136,"tender_id":137,"source_name":10,"source_award_id":138,"source_url":139,"award_notice_type":23,"award_date":125,"publication_date":107,"lot_number":25,"contract_title":140,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":141,"buyer_name":33,"region_code":60,"cpv_code":35,"tender_published_at_utc":112,"tender_deadline_utc":8},421017,24827,"370542-2026","https://ted.europa.eu/de/notice/-/detail/370542-2026","Tiotropium + Olodaterol, ATC R03AL06","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Tiotropium + Olodaterol, ATC R03AL06 für die Zeit 01.06.2024 - 31.05.2026",{"award_id":143,"tender_id":144,"source_name":10,"source_award_id":145,"source_url":146,"award_notice_type":23,"award_date":147,"publication_date":148,"lot_number":25,"contract_title":149,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":46,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":150,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":151,"tender_deadline_utc":8},368940,27158,"308503-2026","https://ted.europa.eu/de/notice/-/detail/308503-2026","2024-05-01T00:00:00.000Z","2026-05-06T00:00:00.000Z","Megestrol, ATC L02AB01","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Megestrol, ATC L02AB01 für die Zeit 01.05.2024 - 30.04.2026","2026-05-05T22:00:00.000Z",{"award_id":153,"tender_id":154,"source_name":10,"source_award_id":155,"source_url":156,"award_notice_type":23,"award_date":147,"publication_date":148,"lot_number":25,"contract_title":157,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":158,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":151,"tender_deadline_utc":8},369037,26906,"309964-2026","https://ted.europa.eu/de/notice/-/detail/309964-2026","Sofosbuvir und Velpatasvir , ATC J05AP55","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Sofosbuvir und Velpatasvir, ATC J05AP55 für die Zeit 01.05.2024 - 30.04.2026",{"award_id":160,"tender_id":161,"source_name":10,"source_award_id":162,"source_url":163,"award_notice_type":23,"award_date":164,"publication_date":165,"lot_number":25,"contract_title":166,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":167,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":168,"tender_deadline_utc":8},343105,36020,"147007-2026","https://ted.europa.eu/de/notice/-/detail/147007-2026","2024-03-01T00:00:00.000Z","2026-03-03T00:00:00.000Z","Budesonid, ATC A07EA06","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Budesonid, ATC A07EA06 für die Zeit 01.03.2024 - 28.02.2025 (zzgl. Verlängerungsoption 1x12 Monate)","2026-03-02T23:00:00.000Z",{"award_id":170,"tender_id":171,"source_name":10,"source_award_id":172,"source_url":173,"award_notice_type":23,"award_date":174,"publication_date":175,"lot_number":25,"contract_title":176,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":177,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":178,"tender_deadline_utc":8},511771,40148,"70719-2026","https://ted.europa.eu/de/notice/-/detail/70719-2026","2024-02-01T00:00:00.000Z","2026-01-30T00:00:00.000Z","Teriparatid, ATC H05AA02","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Teriparatid, ATC H05AA02 für die Zeit 01.02.2024 - 31.01.2026","2026-01-29T23:00:00.000Z",{"award_id":180,"tender_id":181,"source_name":10,"source_award_id":182,"source_url":183,"award_notice_type":23,"award_date":174,"publication_date":184,"lot_number":25,"contract_title":185,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":186,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":187,"tender_deadline_utc":8},508276,40196,"65166-2026","https://ted.europa.eu/de/notice/-/detail/65166-2026","2026-01-29T00:00:00.000Z","Follitropin alfa, ATC G03GA05","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Follitropin alfa, ATC G03GA05 für die Zeit 01.02.2024 - 31.01.2026","2026-01-28T23:00:00.000Z",{"award_id":189,"tender_id":190,"source_name":10,"source_award_id":191,"source_url":192,"award_notice_type":23,"award_date":193,"publication_date":194,"lot_number":25,"contract_title":119,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":195,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":196,"tender_deadline_utc":8},363915,42393,"26169-2026","https://ted.europa.eu/de/notice/-/detail/26169-2026","2024-01-01T00:00:00.000Z","2026-01-14T00:00:00.000Z","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Formoterol + Beclometason (ausschließlich Dafo. DOS), ATC R03AK08 für die Zeit 01.01.2024 - 31.12.2025","2026-01-13T23:00:00.000Z",{"award_id":198,"tender_id":199,"source_name":10,"source_award_id":200,"source_url":201,"award_notice_type":23,"award_date":193,"publication_date":202,"lot_number":25,"contract_title":203,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":204,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":205,"tender_deadline_utc":8},348888,42588,"18894-2026","https://ted.europa.eu/de/notice/-/detail/18894-2026","2026-01-13T00:00:00.000Z","Maraviroc, ATC J05AX09","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Maraviroc, ATC J05AX09 für die Zeit 01.01.2024 - 31.12.2025","2026-01-12T23:00:00.000Z",{"award_id":207,"tender_id":208,"source_name":10,"source_award_id":209,"source_url":210,"award_notice_type":23,"award_date":193,"publication_date":202,"lot_number":25,"contract_title":211,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":212,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":205,"tender_deadline_utc":8},350045,42472,"19177-2026","https://ted.europa.eu/de/notice/-/detail/19177-2026","Paliperidon (ausschließlich 3-Monats-Depot), ATC N05AX13","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Paliperidon (ausschließlich 3-Monats-Depot), ATC N05AX13 für die Zeit 01.01.2024 - 31.12.2025",{"award_id":214,"tender_id":215,"source_name":10,"source_award_id":216,"source_url":217,"award_notice_type":23,"award_date":218,"publication_date":202,"lot_number":25,"contract_title":219,"winner_name":7,"winner_identifier":220,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":221,"buyer_name":33,"region_code":60,"cpv_code":35,"tender_published_at_utc":205,"tender_deadline_utc":8},350260,42651,"19342-2026","https://ted.europa.eu/de/notice/-/detail/19342-2026","2025-05-01T00:00:00.000Z","Peginterferon beta-1a, ATC L03AB13","HRB13886","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Peginterferon beta-1a, ATC L03AB13 für die Zeit 01.05.2025 - 30.04.2027",{"award_id":223,"tender_id":224,"source_name":10,"source_award_id":225,"source_url":226,"award_notice_type":23,"award_date":193,"publication_date":202,"lot_number":25,"contract_title":227,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":228,"buyer_name":33,"region_code":34,"cpv_code":35,"tender_published_at_utc":205,"tender_deadline_utc":8},358125,42515,"21340-2026","https://ted.europa.eu/de/notice/-/detail/21340-2026","Buserelin, ATC L02AE01","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Buserelin, ATC L02AE01 für die Zeit 01.01.2024 - 31.12.2025",{"award_id":230,"tender_id":231,"source_name":10,"source_award_id":232,"source_url":233,"award_notice_type":23,"award_date":8,"publication_date":234,"lot_number":8,"contract_title":235,"winner_name":7,"winner_identifier":8,"winner_country":8,"value_eur":8,"currency":8,"confidence":110,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":236,"buyer_name":48,"region_code":34,"cpv_code":35,"tender_published_at_utc":237,"tender_deadline_utc":8},43720,25189,"727715-2025","https://ted.europa.eu/de/notice/-/detail/727715-2025","2025-11-04T00:00:00.000Z","Abschluss eines nicht-exklusiven Rabattvertrages gemäß §130c Abs. 1 SGB V zwischen der IKK classic und der EurimPharm Arzneimittel GmbH zu Skyrizi(R)","Deutschland – Arzneimittel – Abschluss eines nicht-exklusiven Rabattvertrages gemäß §§ 130a Abs. 8 und 130c Abs. 1 SGB V zwischen der IKK classic und der Novartis Pharma GmbH zu Rhapsido","2026-05-27T22:00:00.000Z",{"award_id":239,"tender_id":240,"source_name":10,"source_award_id":241,"source_url":242,"award_notice_type":23,"award_date":174,"publication_date":243,"lot_number":25,"contract_title":244,"winner_name":7,"winner_identifier":27,"winner_country":9,"value_eur":8,"currency":28,"confidence":29,"visibility":30,"access_tier":31,"company_slug":6,"company_name":7,"website_url":8,"tender_title":245,"buyer_name":33,"region_code":60,"cpv_code":35,"tender_published_at_utc":246,"tender_deadline_utc":8},506421,58142,"634636-2025","https://ted.europa.eu/de/notice/-/detail/634636-2025","2025-09-29T00:00:00.000Z","Mesalazin, ATC A07EC02","Deutschland – Arzneimittel – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Mesalazin, ATC A07EC02 für die Zeit 01.02.2024 - 31.01.2026","2025-09-28T22:00:00.000Z",{"company_slug":6,"years":248,"award_count":14,"top_buyers":249,"yearly_trend":263},5,[250,255,259],{"buyer_name":33,"buyer_key":251,"award_count":252,"total_value_eur":253,"share_count":254},"dak-gesundheit",25,2,0.862,{"buyer_name":48,"buyer_key":256,"award_count":257,"total_value_eur":46,"share_count":258},"ikk-classic",3,0.103,{"buyer_name":260,"buyer_key":261,"award_count":46,"total_value_eur":46,"share_count":262},"Techniker Krankenkasse","techniker-krankenkasse",0.034,[264,266,268],{"year":265,"award_count":46},2024,{"year":267,"award_count":248},2025,{"year":269,"award_count":270},2026,23]